Uncategorized Archives - Page 73 of 251

TuesdayJul 13, 2021 10:19 am

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Line of Products Addresses Declining Minerals in Food Supply

Soil depletion causing mineral loss in food supply BevCanna’s TRACE line of products address issue through proprietary plant-based formula rich in iron, magnesium, calcium, potassium Company recently signed distribution agreement to reach target markets in New York, Chicago, California BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, helps consumers address nutrient deficiencies with its TRACE line of beverages and supplements. Sourced from deep within British Columbia’s Rocky Mountains, TRACE products are high in fulvic and humic minerals, providing an easily absorbed source of minerals such as iron, magnesium, calcium, potassium…

MondayJul 12, 2021 11:31 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Delists from CSE to Focus Efforts on Most Effective Drug Platform Outcomes

Lexaria Bioscience is a drug bioavailability platform developer intent on providing an effective oral administration alternative to smoking that duplicates the rapid assimilation benefits of inhalation without the lung-harmful effects The company’s DehydraTECH IP is being evaluated for concentration levels, tolerability and ability to transform partner drugs to oral solutions without incidentally creating new molecular entities Lexaria announced voluntary delisting from the Canadian Securities Exchange this month in order to focus its resources more effectively on its Nasdaq listing The company’s leadership recently interacted with investors in the Life Sciences Investor Forum virtual conference series and the company’s annual meeting…

ThursdayJul 08, 2021 12:04 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive Results From its Recent Animal Study on the Effectiveness of its DehydraTECH Drug Delivery Technology

Lexaria Bioscience Corp. announced positive results from its VIRAL-A20-2 study This study showed strong gains in delivery of the DehydraTECH-enabled remdesivir and ebastine among animals The success of this study shows the potential and commercial viability of Lexaria’s DehydraTECH In June 2021, Lexaria Bioscience (NASDAQ: LEXX) announced positive results from its VIRAL-A20-2 study that evaluated the effectiveness of DehydraTECH-enabled remdesivir and ebastine among animals. The results were strongly positive and demonstrated greater effectiveness than in Lexaria’s first antiviral drug study reported in December 2000. The research was a tolerability and pharmacokinetic (“PK”) study involving four groups of 10 animals each.…

WednesdayJul 07, 2021 12:03 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Positioning Itself to Compete in US Functional Beverage Market

“Forbes” article notes that $20 million Naturo Group acquisition creates ideal situation for BevCanna expansion BevCanna boasts one of most unique, diverse portfolios of beverage and natural health products within both cannabis, plant-based industries Combination of two Canadian beverage industry leaders unlocks significant potential for growth As Canadian cannabis company BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) expands its infused functional beverage business into the United States, its deliberate, transformative strategy has garnered a mention in a recent “Forbes” article. Titled “BevCanna Expands in the U.S. Infused Functional Beverage Market Upon Acquiring Naturo Group,” the article noted that the…

TuesdayJul 06, 2021 9:30 am

Hero Technologies Inc. (HENC) Is Leading Cannabis Player as Trend Moves Toward Greenhouse Cultivation

Greenhouse production continues to be the no. 1 tool for reducing initial operational costs. The report analyzed five years of data to identify key trends in the cannabis cultivation market. The average cost to grow a pound of dried flower was $396 for warehouse cultivation sites, only $233 for greenhouse sites. According to a recent five-year study of the cannabis industry, greenhouse production is a leading choice for cannabis cultivation companies (https://cnw.fm/1JlbG). The report, published by “Cannabis Business Times,” reaffirms the business strategy of Hero Technologies (OTC: HENC), a cannabis company that is focused on growing into a multistate, vertically integrated entity…

TuesdayJul 06, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Announces Milestone in Antiviral Delivery Platform Testing

Drug delivery platform developer Lexaria Bioscience has been testing its patented technology in conjunction with antivirals Remdesivir and Ebastine during the past year to determine the potential for enhancing their effectiveness against the COVID-19 virus Early-stage testing has determined Lexaria’s technology — DehydraTECH — did not inhibit Remdesivir and Ebastine in their use against the virus DehydraTECH is a technology that helps drugs gain better bioavailability through effective introduction into patients’ bloodstreams The DehydraTECH platform has also shown great potential in enhancing hypertension medication and additional trials are ongoing Pharmaceutical use and bioavailability innovator Lexaria Bioscience (NASDAQ: LEXX) (CSE: LXX)…

FridayJul 02, 2021 12:36 pm

Chalice Farms to Celebrate Cannabis Industry Holiday, National Oil Day, With Discounts on Concentrates, Dab Bus Pop-Up Experience and Collaboration with Local Artist

Tweet it: Enjoy discounts @ChaliceFarms this #710 on ALL dabs and toke up on the Dab Bus! #NationalDabDay #NationalOilDay #Oregon #Cannabis PORTLAND –Chalice Farms will celebrate cannabis industry holiday, National Oil Day, with specials on cannabis concentrates, a collaboration with local artist, Damien Gilley, and a pop-up dab bus experience on Saturday, July 10. In honor of National Oil Day on Saturday, 7/10, which spells “OIL” upside-down, Chalice Farms will offer 30% off all dab products, 20% off all cartridges and discounts on products from Elysium Fields, Bobsled and White Label extracts from Friday, July 9 through Sunday, July 11.…

ThursdayJul 01, 2021 12:09 pm

Golden Triangle Ventures Inc. (GTVH) Announces Acquisition of Wine/Olive Oil Co., Plan to Launch Products for World to Enjoy

GTVH closes on acquisition of the Lodge Winery & Olive Oil Co. under the company’s Food & Wine Division, Napa Wine Brands Inc. Included in the acquisition is a wide range of brands and products. Company committed to broaden horizon of food and wine company by creating a platform different than anything seen in the northern hemisphere. Golden Triangle Ventures (OTC: GTVH) is making a strong statement about its confidence in the $67-billion U.S. wine industry (https://cnw.fm/d3vnX) with its recent acquisition announcement. In May, the company acquired the Lodge Winery & Olive Oil Co. under the company’s Food & Wine…

ThursdayJul 01, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Announces Status Report on Six Key R&D Programs

Lexaria announced significant strides in six of its studies within the 2021 applied R&D program All the studies are based on Lexaria’s DehydraTECH(TM) technology and are designed for multiple market applications, including oral nicotine, NSAIDs, antivirals, and hypertension The 2021 applied R&D program is intended to generate not only confirmatory results and data evidencing but also foster strategic commercial opportunities and corporate relationships Lexaria Bioscience (NASDAQ: LEXX) (CSE: LXX) released a status report on six of its studies in the 2021 applied research and development (“R&D”) program. The program mainly involves studies using DehydraTECH(TM) 2.0 formulations, with different market areas…

WednesdayJun 30, 2021 2:16 pm

XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Mescaline Program for Psychedelic Therapies is on Track

XPhyto Therapeutics Corp (OTCQB: XPHYF) announced its GMP mescaline synthesis program is “on schedule” The program, which started in early 2021, is slated for completion in late Q3 2021 The first initial production batches were completed successfully, marking a significant milestone for the program Mescaline will form a critical component in XPhyto’s psychedelic medicine program and work towards providing a foundation for its drug formulation and clinical validation work XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) recently announced that its Good Manufacturing Practices (“GMP”) mescaline synthesis program in North America is “on schedule” for completion in late Q3 2021…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized